Related Experiment Video
Updated: Aug 7, 2026
In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography
Published on: November 22, 2013
Antibody mediated complete congenital heart block in the fetus
Insights
Complete congenital heart block (CCHB), often caused by maternal autoimmune disease, is diagnosed via echocardiography. While treatments have limited success, understanding risk factors is crucial for managing this rare condition.
Area of Science:
- Cardiology
- Immunology
- Maternal-Fetal Medicine
Background:
- Complete congenital heart block (CCHB) is a rare condition affecting 1:20,000-25,000 live births, typically presenting as atrioventricular block.
- While structural anomalies occur in 30-50% of cases, autoimmune diseases like systemic lupus erythematosus are increasingly recognized as key etiological factors.
- Maternal risk factors, including previous affected child, high anti-Ro antibody titers, presence of anti-Ro (SS-A) and anti-La (SS-B) antibodies, and maternal HLA DR3, confer a high risk for CCHB.
Purpose of the Study:
- To summarize the diagnostic methods for CCHB.
- To discuss risk factors associated with CCHB.
- To review current and potential management strategies for CCHB and its impact on fetal well-being.
Main Methods:
- Diagnosis involves detailed two-dimensional echocardiography to exclude structural anomalies.
- M-mode echocardiography and Doppler blood velocity patterns are used to detect the dissociation between atrial and ventricular rhythms.
- Review of literature regarding risk factors, treatment outcomes, and fetal monitoring challenges.
Main Results:
- CCHB is typically irreversible once established.
- Maternal autoimmune factors, particularly anti-Ro antibodies, are significant contributors.
- Interventions like plasmapheresis, immunosuppression, and steroids have shown limited success in preventing or treating CCHB.
- Underlying maternal immune pathology can compromise utero-placental function, necessitating careful fetal monitoring.
- Conventional fetal heart rate monitoring is often unreliable in affected fetuses.
Conclusions:
- CCHB diagnosis relies on specific echocardiographic findings and identification of maternal risk factors.
- While antibody-mediated CCHB is irreversible, ongoing research explores interventions to mitigate risks.
- Management requires careful monitoring of fetal well-being due to potential utero-placental dysfunction.
- Alternative fetal monitoring strategies are essential when CCHB is present.
Abstract:
Complete congenital heart block (CCHB) affects 1:20,000-25,000 live births and is usually an atrioventricular block; 30-50% of fetuses with CCHB will have a structural anomaly, though recently attention has focused on the etiological influence of autoimmune disease, such as systemic lupus-erythematosus. The diagnosis is established by detailed two-dimensional ultrasound scanning of the heart to exclude anomaly coupled with M-mode echocardiography and Doppler blood velocity patterns in the major vessels to detect the uncoupling of atrial and ventricular rhythms. Risk factors for an affected child are discussed. A previously affected child, high titers of anti-Ro antibodies, the presence of anti-Ro (SS-A) and anti-La (SS-B), and maternal HLA DR3 confer high risk. Antibody mediated CCHB is irreversible. Plasmapheresis and immunosuppression have been attempted in affected mothers, with limited success, to reduce the likelihood of the fetus being affected, and steroids have been used to reduce the inflammatory reaction in the heart. In many cases the underlying pathology of the immune system adversely affects utero-placental function requiring careful monitoring of fetal well-being. CCHB renders fetal heart rate monitoring virtually useless, in the antenatal and intrapartum periods. Alternatives are explored.
Related Concept Videos
01:15Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...